4[1]Goldstein JM. Atypical antipsychotic drugs :beyond acute psychosis, new directions. Emerging Drugs, 1999,4:127
5[2]Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry,1997,54:549
6[3]Borison RL, Arvanitis LA, Miller BG. ICI 204.636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US Seroquel Study Group. J Clin Psychopharmacol, 1996,16:158
7[4]Arvanitis LA,Miller BG and the Seroquel Trial 13 Group.Multiple fixed doses of "Seroquel"(quetiapine) in patients with acute exacerbation of schizophrenia:a comparison with haloperiadaol and placebo.Biol Psychiatry,1997,42:233
8[5]Beasley CM,Sanger T,Satterlee W,et al.Olanzapine versus placebo:results of double-blind,fixed dose olanzapine trail.Psychopharmacology,1996,124:159
9[6]Tran PV,Hamilton SH,Kuntz AJ,et al.Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
10[7]Kasper S,Muller-Spahn F.Review of quetiapine and its clinical applications in schizophrenia.Exp Opin Pharmacother,2000,1:783
